Back to search
FDAFDA · Food and drugs·Recall number D-0647-2017

Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05

Published April 12, 2017 · Recall initiated: March 16, 2017

Summary

FDA records drug Class III recall D-0647-2017, published April 12, 2017 and initiated March 16, 2017. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 118,224 vials; Lot: Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide within the US
Lot
Lot #: 6111141, Exp. 07/17; 6111222, Exp. 08/17; 6112346, Exp. 01/18; 6112725, Exp. 03/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05 recalled?

Yes. FDA published recall D-0647-2017 on April 12, 2017. Reported hazard: Subpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter